NewswireTODAY - /newswire/ - Le Perray en Yvelines, Yvelines, France, 2008/07/02 - tebu-bio, today announced its first ADME seminar in Paris to celebrate 10 years serving the ADME-Tox community (October 9th; Maison de la Chimie, France) - tebu-bio.com.

This first ADME seminar, “From in vitro ADME studies to pharmacokinetics prediction”, aims to provide European experts with an overview of the latest technologies in the ADME-Tox and early-ADME fields. Scientists will get an accurate picture of ADME-Tox properties, drug-drug interactions, transporters assessment and pharmacokinetics prediction. The participants will have the opportunity to discuss their upcoming projects and research programs with tebu-bio product specialists and leading world-wide manufacturers (Advancell, Cypex, Noray Bio, Solvo Biotechnology, Xenotech, tebu-bio laboratories).

“We wanted to develop the European ADME-Tox network by creating a forum where experts in the ADME-Tox enviroment can discuss the latest advances in their field.” said Donald van Dijk, CEO of tebu-bio.

“It’s a fantastic opportunity to thank our ADME customers who have worked with us for the last 10 years, since tebu-bio became the first company to introduce cryopreserved hepatocytes in Europe” added Dr Lecommandeur, VP Business Development Manager.

This seminar will take place in the historic French conference centre “La Maison de la Chimie” in Paris (room 201; October 9th, 2008).

Seminar programme, registration form, and accommodation details are available online.

About tebu-bio

tebu-bio (tebu-bio.com) is an expert in the supply and distribution of reagents for Life Sciences research in Europe and has its own R&D laboratories which provide contract services.
tebu-bio is selected as a provider by the most demanding customers and is chosen as a distribution partner by renowned specialized providers. With more than 425,000 specialized reagents, tebu-bio’s on-line catalogue tebu-bio.com is updated daily in the fields of ADME-tox studies but also recombinant protein production, pharmaceutical target validation, molecular screening and cell-based assays. This broad range of reagents and services puts tebu-bio in a strong position to supply the largest international pharmaceutical companies, biotech organizations and Research Institutes in Europe.

tebu-bio: the smarter way to buy research products in Europe

Agency / Source: tebu-bio

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick NewswireToday Visibility Checker

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]